#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cardiac arrest Myeloid leukaemia Microscopic polyangiitis Small cell lung cancer recurrent Sickle cell disease Pelizaeus-Merzbacher disease Transitional cell cancer of the renal pelvis and ureter Staphylococcal infection Hormone-dependent prostate cancer Cutaneous T-cell lymphoma stage II HER2 gene amplification Chronic graft versus host disease in skin Small intestine leiomyosarcoma Vascular calcification Thymic carcinoma More trials…

    Learn about Rare Diseases

    Haemophilia B with anti factor IX – Treatment Mucopolysaccharidosis – Basic Information Fragile X syndrome – Treatment Cystic fibrosis lung – Trials in Disease Medulloblastoma Primary mediastinal large B-cell lymphoma – Treatment Medulloblastoma – Trials in Disease Myelodysplastic syndrome Marginal zone lymphoma refractory – Diagnostics Vascular malformation – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ALE.P03 VIPOGLANSTAT Avb-101 T89 AZD0120 Adezunap Lysine Hydrochloride Asciminib Amylase Estradiol Valerate Alternaria Alternata (402) Cldn6 Car-T Pralsetinib Saruparib TRONTINEMAB Estradiol Volrustomig Insulin Human (Rdna) METAMIZOLE SODIUM Adrc More therapies…

    Learn about Your Condition

    Primary biliary cholangitis Extraskeletal ossification Neurodermatitis Lung adenocarcinoma Lip and/or oral cavity cancer Thalassaemia Thrombocytopenia Alcoholic liver disease Prostate cancer Pneumonia bacterial Encephalitis Japanese B Somatic symptom disorder Thrombotic microangiopathy Hypophosphatasia Tympanic membrane hyperaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Endocrine ophthalmopathy

  • Study on the Effectiveness and Safety of VRDN-003 for Patients with Chronic Thyroid Eye Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • VRDN-003
    Germany Hungary The Netherlands Poland Spain

  • Study on Batoclimab for Treating Patients with Active Thyroid Eye Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Batoclimab
    Germany Italy Poland

  • Study of Lu AG22515 for Adults with Moderate-to-Severe Thyroid Eye Disease

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Human (Scfv)2-Fab Fusion Protein Against Cd40L
    Bulgaria Germany Poland Spain

  • Study of Efgartigimod PH20 SC for Adults with Thyroid Eye Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Efgartigimod Alfa
    Austria Bulgaria France Germany Italy Latvia +4

  • Study of Efgartigimod for Adults with Thyroid Eye Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Efgartigimod Alfa
    Belgium Bulgaria Czechia Estonia Germany Greece +4

  • Study on the Safety and Effectiveness of LASN01 for Patients with Thyroid Eye Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Lasn01
    • Water For Injection
    • Sodium Chloride
    Germany Spain
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!